Survival, histopathological and biochemical analyses of wild-type and PAD4-deficient CMV-Cre; PAD4fl/fl mice with septic AKI were applied to evaluate the efficacy of either pharmacological or genetic NETs interruption in combination with Fn14 blockade. The gene discussed is TNFRSF12A; the disease is acute kidney injury.